These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 32252542

  • 1. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA, Cvancarova M, Høivik ML, Moum B, Vatn MH.
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [Abstract] [Full Text] [Related]

  • 2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 3. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S, O'Sullivan M, O'Morain CA, Ryan BM.
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [Abstract] [Full Text] [Related]

  • 5. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
    Lawrance IC, Murray K, Hall A, Sung JJ, Leong R.
    Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
    [Abstract] [Full Text] [Related]

  • 6. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
    Forcione DG, Rosen MJ, Kisiel JB, Sands BE.
    Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
    [Abstract] [Full Text] [Related]

  • 7. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjønneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB.
    Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
    [Abstract] [Full Text] [Related]

  • 8. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
    Amre DK, Lu SE, Costea F, Seidman EG.
    Am J Gastroenterol; 2006 Mar; 101(3):645-52. PubMed ID: 16464223
    [Abstract] [Full Text] [Related]

  • 9. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K, Joossens M, Pierik MJ, Jonkers D, Bohr J, Joossens S, Romberg-Camps M, Nyhlin N, Wickbom A, Rutgeerts PJ, Tysk C, Bodin L, Colombel JF, Vermeire S, Halfvarson J.
    J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
    [Abstract] [Full Text] [Related]

  • 10. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M.
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [Abstract] [Full Text] [Related]

  • 12. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E.
    Hepatogastroenterology; 2009 Dec; 56(89):162-6. PubMed ID: 19453050
    [Abstract] [Full Text] [Related]

  • 13. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD, Litwin CM, Hill HR.
    Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
    [Abstract] [Full Text] [Related]

  • 14. Serologic antibodies in relation to outcome in postoperative Crohn's disease.
    Hamilton AL, Kamm MA, De Cruz P, Wright EK, Selvaraj F, Princen F, Gorelik A, Liew D, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Bell SJ, Brown SJ, Connell WR.
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1195-1203. PubMed ID: 27976801
    [Abstract] [Full Text] [Related]

  • 15. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
    Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G.
    Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
    [Abstract] [Full Text] [Related]

  • 16. IBD Serology and Disease Outcomes in African Americans With Crohn's Disease.
    Bertha M, Vasantharoopan A, Kumar A, Bruce BB, Prince J, Hofmekler T, Okou D, Chopra P, Wang G, Sauer C, Landers CJ, Hussain SZ, Cross RK, Baldassano RN, Kappelman MD, Katz J, Alexander JS, Kirschner BS, Moulton DE, Osuntokun BO, Patel A, Saeed S, Klapproth JA, Dhere TA, Dubinsky MC, McGovern D, Kugathasan S.
    Inflamm Bowel Dis; 2017 Dec 19; 24(1):209-216. PubMed ID: 29272484
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK, Mallant-Hent RC, Groothuismink ZM, Bakker-Jonges LE, van de Merwe JP, Hooijkaas H, von Blomberg BM, Meuwissen SG.
    Eur J Gastroenterol Hepatol; 2002 Sep 19; 14(9):1013-8. PubMed ID: 12352222
    [Abstract] [Full Text] [Related]

  • 18. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
    Bertin D, Grimaud JC, Lesavre N, Benelmouloud C, Desjeux A, Garcia S, Desplat-Jégo S.
    PLoS One; 2013 Sep 19; 8(11):e80433. PubMed ID: 24303014
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.